Ford Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25
Closed -$1 251
2021
Q4
$1 Buy
+25
New +$1.72K ﹤0.01% 451
2021
Q3
Sell
-25
Closed -$1K 260
2021
Q2
$1K Buy
+25
New +$1.67K ﹤0.01% 507
2018
Q1
Sell
-185
Closed -$13K 163
2017
Q4
$13K Buy
+185
New +$14K 0.01% 185

Other funds holding GILD

Ford Financial Group's GILD Position: Q1 2022 in Review

Ford Financial Group sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 25 shares — an estimated $1 sold.

Ford Financial Group first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $13K in Q4 2017. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Ford Financial Group reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 25 Gilead Sciences shares in Q1 2022, an estimated $1.
  • Ford Financial Group first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
  • Ford Financial Group's Gilead Sciences position peaked at $13K in Q4 2017.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.